title: Is dual renin-angiotensin-system blockade associated with increased risk of stroke?
authors.affiliation: Division of Cardiology, St. Luke's-Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, New York.
authors.forename: Harikrishna
authors.initials: H
authors.lastname: Makani
authors.affiliation: New York University School of Medicine, New York, New York.
authors.forename: Sripal
authors.initials: S
authors.lastname: Bangalore
authors.affiliation: International Centre for Circulatory Health, Imperial College London, United Kingdom.
authors.forename: Peter
authors.initials: P
authors.lastname: Sever
authors.affiliation: Division of Cardiology, St. Luke's-Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, New York. Electronic address: messerli.f@gmail.com.
authors.forename: Franz H
authors.initials: FH
authors.lastname: Messerli
mesh_terms: D000577:Amides / Q000009:adverse effects*; D057911:Angiotensin Receptor Antagonists / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D005650:Fumarates / Q000009:adverse effects*; D006801:Humans; D012084:Renin-Angiotensin System / Q000187:drug effects*; D018570:Risk Assessment; D020521:Stroke / Q000139:chemically induced* / Q000453:epidemiology*; D000092502:Renin Inhibitors
chemical_list: D000577:Amides; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D005650:Fumarates; D000092502:Renin Inhibitors; C446481:aliskiren